Phosphodiesterases And Cyclic Nucleotide Signaling In The CNS
M. Conti, W. Richter
Published 2014 · Chemistry
Download PDFAnalyze on Scholarcy
This paper references
Immunohistochemical Localization of cGMP-binding cGMP-specific Phosphodiesterase (PDE5) in Rat Tissues
J. Kotera (2000)
Immunohistochemical localization of PDE10A in the rat brain
Thomas Francis Seeger (2003)
Genomic organization of the human phosphodiesterase PDE11A gene
K. Yuasa (2001)
Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs.
X. Miró (2001)
Regulation of cAMP‐specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons
C. D'Sa (2002)
PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
Jennifer J Carlisle Michel (2004)
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
Helmut Wachtel (1983)
Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles.
E. Sutherland (1958)
Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation
J. Prickaerts (2004)
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model
D. Puzzo (2009)
Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: Comparison with rolipram
D. Dlaboga (2006)
Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease.
C. McLachlan (2007)
Differential distribution of PDE4B splice variant mRNAs in rat brain and the effects of systemic administration of LPS in their expression.
Elisabet Reyes-Irisarri (2008)
Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopamine Agonists and Display Impaired Spatial Learning
T. Reed (2002)
Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
A. Iffland (2005)
Interplay of Palmitoylation and Phosphorylation in the Trafficking and Localization of Phosphodiesterase 10A: Implications for the Treatment of Schizophrenia
Erik I. Charych (2010)
cGMP phosphodiesterase of retinal rods is regulated by two inhibitory subunits.
P. Deterre (1988)
Phosphodiesterases in the CNS: targets for drug development
F. Menniti (2006)
dunce, a mutant of Drosophila deficient in learning.
Y. Dudai (1976)
mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain
W. C. V. van Staveren (2003)
Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder
S. Fatemi (2008)
Chronic Suppression of Phosphodiesterase 10A Alters Striatal Expression of Genes Responsible for Neurotransmitter Synthesis, Neurotransmission, and Signaling Pathways Implicated in Huntington's Disease
R. Kleiman (2011)
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
C. Schmidt (2008)
Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocyte cGMP-inhibited cAMP phosphodiesterase.
A. Rascón (1994)
Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion.
Eva L. van Donkelaar (2008)
Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain.
S. Iona (1998)
Attenuation of the Activity of the cAMP-specific Phosphodiesterase PDE4A5 by Interaction with the Immunophilin XAP2*
G. Bolger (2003)
A whole genome association study of neuroticism using DNA pooling
S. Shifman (2008)
Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3)
Y. Shakur (2000)
Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q.
S. Detera-Wadleigh (1996)
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
M. P. Kelly (2010)
Differential expression and regulation of the cAMP‐selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration
C. D'Sa (2005)
Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme
J. Siuciak (2007)
Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases.
H. Charbonneau (1990)
Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1.
J. Yu (1997)
A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.
S. Laddha (2009)
A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia
A. Horvath (2006)
Phosphodiesterase 4B (PDE4B) and cAMP-level regulation within different tissue fractions of rat hippocampal slices during long-term potentiation in vitro
T. Ahmed (2005)
Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation.
T. Sasaki (2002)
Many hypotheses but no replication for the association between PDE4D and stroke
J. Rosand (2006)
Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey
S. Lamontagne (2001)
Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
D. Giordano (2001)
Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors
Helmut Wachtel (2004)
TAPAS-1, a Novel Microdomain within the Unique N-terminal Region of the PDE4A1 cAMP-specific Phosphodiesterase That Allows Rapid, Ca2+-triggered Membrane Association with Selectivity for Interaction with Phosphatidic Acid*
G. Baillie (2002)
Phosphorylation-mediated Activation and Translocation of the Cyclic AMP-specific Phosphodiesterase PDE4D3 by Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinases
H. Liu (1999)
The molecular basis for different recognition of substrates by phosphodiesterase families 4 and 10.
H. Wang (2007)
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
A. Burgin (2010)
Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester.
B. Devan (2007)
Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
S. Threlfell (2009)
Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis
J. Siuciak (2006)
Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats
K. Rutten (2009)
Role of cyclic nucleotides in growth control.
I. Pastan (1975)
Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity.
H. Wang (2008)
The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task
Joshua D. Vardigan (2011)
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding
S. E. Martínez (2002)
Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain
R. R. Reinhardt (1996)
PKA Dynamics in a Drosophila Learning Center: Coincidence Detection by Rutabaga Adenylyl Cyclase and Spatial Regulation by Dunce Phosphodiesterase
N. Gervasi (2010)
The GAFa Domains of Rod cGMP-phosphodiesterase 6 Determine the Selectivity of the Enzyme Dimerization*
K. G. Muradov (2003)
Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7*
H. Wang (2005)
Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.
K. Fujishige (1999)
Multiple cyclic nucleotide phosphodiesterase activities from rat brain.
Thompson Wj (1971)
Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study
X. Miró (2002)
Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation.
Kirsty F Mackenzie (2011)
Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
W. Richter (2001)
Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver. Effects of divalent cations on activity.
T. Yamamoto (1983)
cAMP Is a Ligand for the Tandem GAF Domain of Human Phosphodiesterase 10 and cGMP for the Tandem GAF Domain of Phosphodiesterase 11*
Marco Gross-Langenhoff (2006)
Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population
S. Numata (2009)
Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants.
P. Wang (2003)
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor IBMX binding
Q. Huai (2004)
Association Between Genes of Disrupted in Schizophrenia 1 (DISC1) Interactors and Schizophrenia Supports the Role of the DISC1 Pathway in the Etiology of Major Mental Illnesses
L. Tomppo (2009)
PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6)
Y. Cheung (2007)
Individual Cerebellar Purkinje Cells Express Different cGMP Phosphodiesterases (PDEs): In Vivo Phosphorylation of cGMP-Specific PDE (PDE5) as an Indicator of cGMP-dependent protein kinase (PKG) Activation
M. Shimizu-Albergine (2003)
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
S. Grétarsdóttir (2003)
A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain
D. Repaske (1993)
Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats
B. Devan (2004)
Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases.
G. B. Bolger (1994)
Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain.
M. P. Kelly (2014)
Cloning and characterization of two splice variants of human phosphodiesterase 11A.
J. M. Hetman (2000)
Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets.
C. Macphee (1988)
Expression of phosphodiesterase 4 is altered in the brains of subjects with autism
Natalie N. Braun (2007)
A Genome-Wide Association Scan of RR and QT Interval Duration in 3 European Genetically Isolated Populations: The EUROSPAN Project
F. Marroni (2009)
Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity.
Q. Huai (2003)
Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
A. Nishi (2008)
Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
D. M. Collins (2008)
Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase.
R. Sharma (1985)
In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits.
J. Anant (1992)
Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
J. Prickaerts (2004)
3′,5′-Cyclic nucleotide phosphodiesterase 11A: localization in human tissues
K. Loughney (2005)
Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct
J. Pandit (2009)
Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain.
Tamaki Kobayashi (2003)
In Vivo Assessment of Local Phosphodiesterase Activity Using Tailored Cyclic Nucleotide–Gated Channels as Camp Sensors
T. C. Rich (2001)
Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals.
M. P. Kelly (2009)
Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)
R. Kakkar (1999)
Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
T. J. Martins (1982)
Functional Chimeras of the Phosphodiesterase 5 and 10 Tandem GAF Domains*
Karina Hofbauer (2008)
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
F. V. D. Staay (2008)
Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules
Byung-Je Sung (2003)
Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence
M. Guipponi (1998)
Expression and role of phosphodiesterase 6 in the chicken pineal gland
F. Morin (2001)
Phosphodiesterase-5 Gln817 Is Critical for cGMP, Vardenafil, or Sildenafil Affinity
R. Zoraghi (2006)
Identification of Inhibitory and Calmodulin-binding Domains of the PDE1A1 and PDE1A2 Calmodulin-stimulated Cyclic Nucleotide Phosphodiesterases (*)
W. K. Sonnenburg (1995)
Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching &bgr;1-Adrenergic but Locally Confined &bgr;2-Adrenergic Receptor–Mediated Signaling
V. Nikolaev (2006)
Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population.
S. Numata (2008)
Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase.
M. Taira (1993)
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
S-L Catherine Jin (2002)
Phosphorylation Increases Affinity of the Phosphodiesterase-5 Catalytic Site for Tadalafil
Emmanuel P. Bessay (2008)
Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene.
C. Rentero (2003)
Cyclic AMP-dependent Transcriptional Up-regulation of Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells
I. L. Le Jeune (2002)
The Oligomerization State Determines Regulatory Properties and Inhibitor Sensitivity of Type 4 cAMP-specific Phosphodiesterases*
W. Richter (2004)
Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect
J. Cherry (1999)
Characterization of an intronic promoter of a cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility.
E. Vicini (1997)
The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D
F. Mori (2010)
Functions of the N-terminal Region of Cyclic Nucleotide Phosphodiesterase 3 (PDE 3) Isoforms*
Y. Ke-nan (2000)
Genome-wide association of sleep and circadian phenotypes
D. Gottlieb (2007)
Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography: Comparison with monkey and rat brain
S. Pérez-Torres (2000)
Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
S. Herman (2000)
Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
N. I. Piriev (1998)
A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding
A. Zhao (2002)
Molecular organization of bovine rod cGMP-phosphodiesterase 6.
J. F. Kameni Tcheudji (2001)
Insulin-sensitive phosphodiesterase. Its localization, hormonal stimulation, and oxidative stabilization.
T. Kôno (1975)
Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
Karina Matthiesen (2009)
cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists.
J. Jurevičius (1996)
Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression*
K. Yuasa (2000)
A-Kinase Anchoring Proteins Interact with Phosphodiesterases in T Lymphocyte Cell Lines1
Angela L. Asirvatham (2004)
PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia
S. Fatemi (2008)
Isoform-Selective Susceptibility of DISC1/Phosphodiesterase-4 Complexes to Dissociation by Elevated Intracellular cAMP Levels
H. Murdoch (2007)
Localization of 63-kDa calmodulin-stimulated phosphodiesterase mRNA in the rat brain by in situ hybridization histochemistry.
T. Furuyama (1994)
Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain
E. Reyes-Irisarri (2005)
The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
C. Sette (1994)
Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase.
R. Sharma (1991)
First computational evidence for a catalytic bridging hydroxide ion in a phosphodiesterase active site.
C. Zhan (2001)
The Sequence of the Human Genome
J. Venter (2001)
Calmodulin and Ca2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme.
R. Sharma (1986)
Structural basis for the catalytic mechanism of human phosphodiesterase 9
S. Liu (2008)
A novel cyclic GMP stimulated phosphodiesterase from rat brain.
Qinbo Yang (1994)
Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells
N. Oki (2000)
Identification of loci associated with schizophrenia by genome-wide association and follow-up
M. O’Donovan (2008)
Cyclic GMP Phosphodiesterase-5: Target of Sildenafil*
J. Corbin (1999)
Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain
W. C. V. van Staveren (2002)
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
Q. Huai (2004)
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
A. McCahill (2005)
A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway.
D. Juilfs (1997)
Inhibition of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by deprenyl.
R. Kakkar (1996)
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries
M. Talkowski (2012)
Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function
J. Siuciak (2006)
Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase.
S. Soderling (1998)
Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP.
J. Kotera (1999)
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
F. Wunder (2005)
Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants.
W. K. Sonnenburg (1991)
Daily rhythm in pineal phosphodiesterase (PDE) activity reflects adrenergic/3',5'-cyclic adenosine 5'-monophosphate induction of the PDE4B2 variant.
Jong-So Kim (2007)
The Mechanism of Cyclic Nucleotide Hydrolysis in the Phosphodiesterase Catalytic Site
E. Salter (2007)
Regulation of the phosphodiesterase PDE4B3-ISOTYPE during long-term potentiation in the area dentata in vivo
T. Ahmed (2004)
Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Neesha U. Suvarna (2002)
Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation
Kok-Long Ang (2002)
Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change.
Kirsty F Mackenzie (2008)
Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation.
E. Degerman (1990)
Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
W. Richter (2005)
Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme
Han-ting Zhang (2002)
Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid.
G. Némoz (1997)
A placebo-controlled study of sildenafil effects on cognition in schizophrenia
D. Goff (2008)
Genomic structure and chromosome location of the murine PDE1B phosphodiesterase gene
T. Reed (1998)
Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice
A. Hebb (2008)
Comment on the phosphodiesterase 4D replication study by Bevan et al.
S. Grétarsdóttir (2005)
The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
P. H. Hutson (2011)
Expression of the specific type IV phosphodiesterase gene PDE4B3 during different phases of long-term potentiation in single hippocampal slices of rats in vitro
T. Ahmed (2003)
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
R. Álvarez (1995)
Heterozygous missense mutation in the rod cGMP phosphodiesterase β–subunit gene in autosomal dominant stationary night blindness
A. Gal (1994)
Amantadine: an antiparkinsonian agent inhibits bovine brain 60kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme
R. Kakkar (1997)
The Inhibitory γ Subunit of the Rod cGMP Phosphodiesterase Binds the Catalytic Subunits in an Extended Linear Structure*
L. Guo (2006)
Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.
A. Robichaud (2002)
The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP.
J. Swinnen (1989)
The Role of Phosphodiesterases in Schizophrenia
J. Siuciak (2008)
Three-dimensional structure of non-activated cGMP phosphodiesterase 6 and comparison of its image with those of activated forms.
N. Kajimura (2002)
Expression of an Active, Monomeric Catalytic Domain of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5)*
T. L. Fink (1999)
Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo
R. Kleiman (2012)
Differential changes in the expression of cyclic nucleotide phosphodiesterase isoforms in rat brains by chronic treatment with electroconvulsive shock
C. H. Cho (2000)
Phosphodiesterase 11: a brief review of structure, expression and function
A. Makhlouf (2006)
Characterization of a catalytic ligand bridging metal ions in phosphodiesterases 4 and 5 by molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical calculations.
Y. Xiong (2006)
Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
W. Richter (2001)
Expression of cGMP-Specific Phosphodiesterase 9A mRNA in the Rat Brain
S. Andreeva (2001)
A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene
B. Chang (2009)
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
F. Boess (2004)
Species differences in the localization of cGMP‐producing and NO‐responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry
W. C. V. van Staveren (2004)
Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies.
R. Sharma (1984)
Discrete Microdomains with High Concentration of cAMP in Stimulated Rat Neonatal Cardiac Myocytes
M. Zaccolo (2002)
Developmental expression of calmodulin-dependent cyclic nucleotide phosphodiesterase in rat brain.
M. Billingsley (1990)
Compartmentation of G protein-coupled signaling pathways in cardiac myocytes.
S. Steinberg (2001)
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
A. Bender (2006)
Structural insight into substrate specificity of phosphodiesterase 10
H. Wang (2007)
Increased social interaction in mice deficient of the striatal medium spiny neuron‐specific phosphodiesterase 10A2
H. Sano (2008)
A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell
T. C. Rich (2001)
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
C. Giampà (2009)
The Calmodulin-dependent Phosphodiesterase Gene PDE1C Encodes Several Functionally Different Splice Variants in a Tissue-specific Manner*
C. Yan (1996)
Critical Role of PDE4D in β2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts*
M. D. Bruss (2008)
Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)*
W. Richter (2002)
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module
K. Dodge (2001)
The MAP kinase ERK2 inhibits the cyclic AMP‐specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579
R. Hoffmann (1999)
Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene.
B. Himes (2009)
Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium*
A. P. Barnes (2005)
Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity.
G. Scapin (2004)
Phosphodiesterase 4D and Protein Kinase A Type II Constitute a Signaling Unit in the Centrosomal Area*
K. Taskén (2001)
Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)
Han-ting Zhang (2008)
Human Ca2+/calmodulin-dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization.
H. Michibata (2001)
Immunohistochemical Localization of Calmodulin-Dependent Cyclic Phosphodiesterase in the Human Brain
S. Lal (2004)
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model.
R. Hoffmann (1998)
The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP Levels in hippocampal slices
K. Rutten (2005)
Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism
F. Menniti (2009)
Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase
C. Sette (1996)
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
K. Rutten (2007)
Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation
J. W. Polli (1994)
Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.
Y. Shakur (1995)
The PDE4B gene confers sex-specific protection against schizophrenia
B. Pickard (2007)
Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials
D. Schultheiss (2001)
PGE1 stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases
A. Terrin (2006)
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3
R. Straub (1994)
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
J. Millar (2005)
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response
M. Wong (2006)
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
S. Rybalkin (2003)
Sildenafil (Viagra®): Is there an influence on psychological performance?
H. Grass (2004)
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
Steven M. Grauer (2009)
A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
K. Y. Zhang (2004)
Regulation of cAMP concentration by calmodulin-dependent cyclic nucleotide phosphodiesterase.
R. Sharma (1986)
Characterization of 3':5' cyclic nucleotide phosphodiesterase activities of mouse neuroblastoma N18TG2 cells
M. Giorgi (1993)
Differential recognition of calmodulin-enzyme complexes by a conformation-specific anti-calmodulin monoclonal antibody.
R. S. Hansen (1986)
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)
Simon J MacKenzie (2002)
In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats
A. Marte (2008)
Neurotrophins Elevate cAMP to Reach a Threshold Required to Overcome Inhibition by MAG through Extracellular Signal-Regulated Kinase-Dependent Inhibition of Phosphodiesterase
Y. Gao (2003)
Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.
K. Yuasa (2001)
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways
K. Dodge-Kafka (2005)
Protein Kinase A Phosphorylation of Human Phosphodiesterase 3B Promotes 14-3-3 Protein Binding and Inhibits Phosphatase-catalyzed Inactivation*
D. Palmer (2007)
Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia
A. Rastogi (2009)
Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer’s disease brains examined by in situ hybridization
S. Pérez-Torres (2003)
Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum
D. Dlaboga (2008)
Results of a phase II study of the antidepressant effect of rolipram.
E. Zeller (1984)
Genetic dissection of the learning/memory gene dunce of Drosophila melanogaster.
Y. Qiu (1993)
Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.
M. Conti (2007)
Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization.
X. Miró (2002)
Expression of the cGMP‐specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains
Elisabet Reyes-Irisarri (2007)
Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation
J. Lim (1999)
Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase.
K. Loughney (1999)
Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP‐dependent protein kinase/cyclic AMP‐response element binding protein pathway in primary striatal neurons
T. Sasaki (2004)
Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain
C. Yan (1994)
Refolding, purification, and characterization of human recombinant PDE4A constructs expressed in Escherichia coli.
W. Richter (2000)
Multiple cyclic nucleotide phosphodiesterases.
J. Beavo (1994)
Characterization of the memory gene dunce of Drosophila melanogaster.
Y. Qiu (1991)
Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity.
R. Xu (2000)
Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
S. Soderling (1999)
Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase.
K. Loughney (1998)
Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2'-dibutyryl adenosine 3':k'-monophosphate.
P. Ross (1977)
Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
S. Jacobitz (1996)
Structural basis of phosphodiesterase 6 inhibition by the C‐terminal region of the γ‐subunit
Brandy Barren (2009)
The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging
K. Domek-Łopacińska (2008)
Selective Induction of cAMP Phosphodiesterase PDE4B2 Expression in Experimental Autoimmune Encephalomyelitis
Elisabet Reyes-Irisarri (2007)
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown.
M. Houslay (2010)
N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization.
J. L. Weeks (2007)
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase
Z. Xie (2006)
Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons.
C. Yan (1995)
Autosomal recessive retinitis pigmentosa caused by mutations in the α subunit of rod cGMP phosphodiesterase
S. H. Huang (1995)
This paper is referenced by
Visualization of cyclic nucleotide dynamics in neurons
K. Gorshkov (2014)
Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat
Guibao Gu (2019)